Good Outcomes after Resection of Large Hepatocellular Carcinoma in the Non-Cirrhotic Liver

Vol. 21, No. 5-6, 2004

Free Abstract Article (Fulltext) Article (PDF 178 KB)

Original Paper

Good Outcomes after Resection of Large Hepatocellular Carcinoma in the Non-Cirrhotic Liver
C. Verhoef^a, R.A. de Man^b, P.E. Zondervan^c, M.J.C. Eijkemans^d, H.W. Tilanus^e, J.N.M. IJzermans^e

^aDepartment of Surgical Oncology, Daniel den Hoed Cancer Clinic, Departments of
^bHepato-Gastroenterology,
^cPathology,
^dPublic Health and
^eHepatobiliary and Transplantation Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands

Address of Corresponding Author

Dig Surg 2004;21:380-386 (DOI: 10.1159/000081882)

Key Words

Hepatocellular carcinoma, survival
Liver, non-cirrhotic
Resection, liver

Abstract

Background: The results of partial liver resection of hepatocellular carcinoma (HCC) in non-cirrhotic livers are not well known. Therefore a retrospective study was conducted. Methods: The medical records of 180 patients with HCC were reviewed. In 40 patients (22%), HCC occurred in a non-cirrhotic liver. A detailed analysis of these patients was performed. The diagnosis HCC was based on imaging and/or percutaneous ultrasound-guided biopsy. A biopsy of the remaining liver and peroperative findings documented the absence of cirrhosis. Results: Twenty-two patients underwent partial liver resection. There was no surgical mortality. The median tumour diameter in the operated patients was 10 cm. Survival rates for operated patients at 1 and 5 years were 96 and 68%, respectively. Significant factors reducing survival were portal vein thrombosis, positive lymph nodes, microscopic vascular invasion and tumour recurrence. Tumour size at the initial moment of diagnosis was not of predictive value. After surgery with curative intent disease-free interval at 1 and 5 years were 86 and 56%, respectively. Conclusion: In selected patients without cirrhosis, HCC can be treated successfully by surgical resection, independent of the tumour diameter, with a 5-year survival rate of 68%.

Author Contacts

C. Verhoef, MD, Department of Surgical Oncology
Daniel den Hoed Cancer Clinic, Erasmus Medical Center
Groene Hilledijk 301
NL-3075 EA Rotterdam (The Netherlands)
Tel. +31 10 4391793, Fax +31 10 4391011, E-mail c.verhoef@erasmusmc.nl

Article Information

Received: January 16, 2004
Accepted: July 7, 2004
Published online: October 29, 2003
Number of Print Pages : 7
Number of Figures : 2, Number of Tables : 4, Number of References : 35

Medline Abstract (ID 15523181)

Download Citation

Cited In

This journal is part of the third subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.